We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACST market cap is 25.87M. The company's latest EPS is USD -0.9511 and P/E is -0.61.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 196k | 0 | 0 |
| Operating Income | -45.02M | -24.44M | -16.01M | -15.34M | -52.16M |
| Net Income | -51.57M | -25.51M | -19.68M | -9.82M | -42.43M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 48.47M | 22.85M | 62.46M | 128.62M | 79.12M |
| Total Liabilities | 34.51M | 9.86M | 6.8M | 20.35M | 11.17M |
| Total Equity | 13.96M | 12.99M | 55.66M | 108.27M | 67.96M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.48M | -22.94M | -14.32M | -17.23M | -15.91M |
| Investing | -12.14M | 8.14M | -9.86M | -3.52M | 13.15M |
| Financing | 58.86M | 13.18M | 59.49M | N/A | 304k |
| Market Cap | 25.87M |
| Price to Earnings Ratio | -0.61 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.93 |
| Price to Book Ratio | 0.38 |
| Dividend Yield | - |
| Shares Outstanding | 44.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.4 (40.82%) |
| Company Name | Acasti Pharma Inc |
| Address |
3009 boul. de la concorde east, suite 102 quebec city, quebec H7E 2B5 |
| Website | https://www.acastipharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
